GlassScriptPhysician profile
Danielle M Klapka
NPI 1649284340
$1,263.66
in general payments reported to CMS, 2019-2025
11 companies · $290 in 2025
The $290 reported for 2025 was more than what 89% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.27 · 2022: $210 · 2023: $446 · 2024: $289 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.97 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $560.67 | 2023-2024 | Veozah |
| Exeltis, USA INC. | $191.26 | 2022-2024 | Slynd |
| Sage Therapeutics, LLC | $159.35 | 2021-2025 | Zurzuvae |
| Biogen, INC. | $125.00 | 2025 | Zurzuvae |
| Abbvie INC. | $62.68 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.28 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $31.29 | 2022-2023 | |
| Supernus Pharmaceuticals, INC. | $28.17 | 2025 | Qelbree |
| Scynexis, INC. | $25.49 | 2022 | |
| Hologic Sales and Service, LLC | $23.97 | 2025 | Thinprep 2000 Processor |
| Ethicon US, LLC | $23.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Klapka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.